Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Telomere Therapeutics Logo
Telomere Therapeutics Growth Score
35
CB Rank
99189
Heat Score
8
Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis
Founded
obfuscation
PrivateSeed Barcelona, Catalonia, Spain1-10 telomere-tx.com/
Biotechnology
Overview

Telomere Therapeutics
Total Funding
obfuscation
Growth Score
35
Heat Score
8

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score35
-1 pts
in past quarter
Heat Score 8
-30 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Telomere Therapeutics

CB Rank
99189
Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis
Founded
obfuscation
PrivateSeed Barcelona, Catalonia, Spain1-10 telomere-tx.com/
Biotechnology

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name TELOMERE THERAPEUTICS, S.L.
Operating Status Active
Company Type For Profit
Founders  Fàtima Bosch, Maria Blasco, Paula Martínez
About the Company
Telomere Therapeutics creates gene therapy based on telomerase gene expression for the treatment of age-related diseases like idiopathic pulmonary fibrosis, aplastic anemia, or dyskeratosis congenita.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AAV-TERT-01
An AAV-based gene therapy designed to express telomerase in lung alveolar epithelial cells to treat idiopathic pulmonary fibrosis by repairing telomeres.
AAV-TERT-02
A gene therapy candidate using AAV vectors to express telomerase for treating undisclosed telomere-dysfunction related diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Telomere Therapeutics Logo
Seed Round - Telomere Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Telomere Therapeutics Logo
Seed Round - Telomere Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Telomere Therapeutics Logo
Seed Round - Telomere Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Telomere Therapeutics Logo
Seed Round - Telomere Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Telomere Therapeutics Logo
Seed Round - Telomere Therapeutics
2
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Telomere Therapeutics Logo
Seed Round - Telomere Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Telomere Therapeutics Logo
Seed Round - Telomere Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Telomere Therapeutics Logo
Seed Round - Telomere Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Telomere Therapeutics Logo
Seed Round - Telomere Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Telomere Therapeutics Logo
Seed Round - Telomere Therapeutics
2
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 1

Employee Profiles

News

News and Press

News•Dec 1, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

107

Active Website Tech Count

15Telomere Therapeutics is actively using 15 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  Apple Mobile Web Clips Icon.

Total IP

2Telomere Therapeutics has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Telomere Therapeutics has 1 registered trademark in the 'Pharmaceutical, veterinary and sanitary products' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Telomere Therapeutics's headquarters? Telomere Therapeutics is located in Barcelona, Catalonia, Spain.Who invested in Telomere Therapeutics? Telomere Therapeutics has 2 investors including Invivo Capital Partners and  CDTI.When was the last funding round for Telomere Therapeutics? Telomere Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are Telomere Therapeutics's competitors? Alternatives and possible competitors to Telomere Therapeutics may include Roche, Bristol-Myers Squibb, and  Boehringer Ingelheim.How much funding has Telomere Therapeutics raised to date? Telomere Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|